Case series of rosiglitazone used during the first trimester of pregnancy

Reproductive Toxicology

Volumn 26, Issue 2, 2008, Pages 183-184

  Haddad, Ghassan F ^a   Jodicke, Cristiano ^a   Thomas, Michael A ^a   Williams, Daniel B ^a   Aubuchon, Mira ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Anovulation; Insulin sensitizer; Metformin; Miscarriage; Polycystic ovarian syndrome (PCOS); Pregnancy; Rosiglitazone

Indexed keywords

CLOMIFENE CITRATE; GONADOTROPIN; INSULIN SENSITIZING AGENT; METFORMIN; ROSIGLITAZONE;

ADULT; ARTICLE; CHILDBIRTH; CLINICAL ARTICLE; CONGENITAL MALFORMATION; DRUG SUBSTITUTION; FEMALE; FEMALE INFERTILITY; FIRST TRIMESTER PREGNANCY; GASTROINTESTINAL SYMPTOM; GESTATION PERIOD; HUMAN; INSULIN SENSITIVITY; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY COMPLICATION; RISK BENEFIT ANALYSIS;

ADULT; ANOVULATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; OVULATION; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; THIAZOLIDINEDIONES;

EID: 53249143946     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2008.08.001     Document Type: Article

References (19)

1. Knochenhauer E.S., Key T.J., Kahsar-Miller M., Waggoner W., Boots L.R., and Azziz R. Prevalence of the polycystic ovary syndrome in unselected Black and White women of the southeastern United States: a prospective study. J. Clin Endocrinol Metab 83 (1998) 3078-3082
2. Glueck C.J., Phillips H., Cameron D., Sieve-Smith L., and Wang P. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril 75 (2001) 46-52
3. Glueck C.J., Bornovali S., Pranikoff J., Goldenberg N., Dharashivkar S., and Wang P. Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome. Diabetic Med 21 (2004) 829-836
4. Rouzi A.A., and Ardawi M.S. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome. Fertil Steril 85 (2006) 428-435
5. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7.
6. Unluhizarci K., Kelestimur F., Bayram F., Sahin Y., and Tutus A. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 51 (1999) 231-236
7. Glueck C.J., Wang P., Kobayashi S., Phillips H., and Sieve-Smith L. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 77 (2002) 520-525
8. Glueck C.J., Wang P., Goldenberg N., and Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 17 (2002) 2858-2864
9. Palomba S., Falbo A., Orio Jr. F., Russo T., Tolino A., and Zullo F. Metformin hydrochloride and recurrent miscarriage in a woman with polycystic ovary syndrome. Fertil Steril 85 (2006) 1511.e3-1511.e5
10. Legro R.S., Zaino R.J., Demers L.M., Kunselman A.R., Gnatuk C.L., Williams N.I., et al. The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome. Am J Obstet Gynecol 196 (2007) 402.e1 10; discussion 402.e10-1
11. Ma L.K., Jin L.N., Yu Q., and Xu L. Effect of lifestyle adjustment, metformin and rosiglitazone in polycystic ovary syndrome. Zhonghua Fu Chan Ke Za Zhi 42 (2007) 294-297
12. Center for Drug Evaluation and Labeling. NDA 21-071/S-004 Labeling. 2003; Available at: http://www.fda.gov/cder/foi/nda/2003/021071_S004_AVANDIA.pdf.
13. Klinkner D.B., Lim H.J., Strawn J., Estil Y., Oldham K.T., and Sander T.L. An in vivo murine model of rosiglitazone use in pregnancy. Fertil Steril 86 (2006) 1074-1079
14. Chan L.Y., Yeung J.H., and Lau T.K. Placental transfer of rosiglitazone in the first trimester of human pregnancy. Fertil Steril 83 (2005) 955-958
15. Yaris F., Yaris E., Kadioglu M., Ulku C., Kesim M., and Kalyoncu N.I. Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman. Reprod Toxicol 18 (2004) 619-621
16. Kalyoncu N.I., Yaris F., Ulku C., Kadioglu M., Kesim M., Unsal M., et al. A case of rosiglitazone exposure in the second trimester of pregnancy. Reprod Toxicol 19 (2005) 563-564
17. Choi J., Han J., Ahn H., Shin J., Yang J., Koong M., et al. Exposure to rosiglitazone and fluoxetine in the first trimester of pregnancy. Diabetes Care 29 (2006) 2176
18. Legro R.S., Barnhart H.X., Schlaff W.D., Carr B.R., Diamond M.P., Carson S.A., et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 356 (2007) 551-566
19. Nissen S.E., and Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356 (2007) 2457-2471